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Oxidoperoxidomolybdenum(VI) complexes with 
acylpyrazolonate ligands: synthesis, structure and catalytic 
properties 
Emilio Begines,a Carlos J. Carrasco,a Francisco Montilla,a Eleuterio Álvarez,b Fabio Marchetti,‡c 
Riccardo Pettinari,‡c Claudio Pettinari,†c and Agustín Galindo*a 
Oxidoperoxido-molybdenum(VI) complexes containing acylpyrazolonate ligands were obtained by reaction of 
[Mo(O)(O)2(H2O)n] with the corresponding acylpyrazolone compounds HQR. Complexes Ph4P[Mo(O)(O2)2(QR)] (R = neopentyl, 
1; perfluoroethyl, 2; hexyl, 3; phenyl, 4; naphthyl, 5; methyl, 6; cyclohexyl, 7; ethylcyclopentyl, 8) were obtained if the 
reaction was carried out with one equivalent of HQR in the presence of Ph4PCl. Alternatively, neutral complexes 
[Mo(O)(O2)(QR)2] (R = neopentyl, 9; hexyl, 10; cyclohexyl, 11) were formed when two equivalents of HQR were used in the 
reaction. These complexes were isolated in good yields as yellow or yellow-orange crystalline solids and were 
spectroscopically (IR, 1H, 13C{1H} and 31P{1H} NMR), theoretically (DFT) and structurally characterised (X-ray for 1, 2, 9 and 
10). Compounds 1 and 9 were selected to investigate their catalytic behaviour in epoxidation of selected alkenes and 
oxidation of selected sulphides, while 10 and 11 were tested as catalyst precursors in the deoxygenation of selected epoxide 
substrates to alkenes, using PPh3 as the oxygen-acceptor. Complexes Ph4P[Mo(O)(O2)2(QR)] were shown to be poor catalyst 
precursors in oxidation reactions, while the activity of [Mo(O)(O2)(QR)2] species is good in all the studied reactions and 
comparable to related oxidoperoxido-molybdenum(VI) complexes. Complex [Mo(O)2(QC6)2], 12, was obtained by treatment 
of 10 with one equivalent of PPh3, demonstrating that the first step in the epoxide deoxygenation mechanism was the oxygen 
atom transfer toward the phosphane. 
Introduction 
Acylpyrazolonate ligands are modified -diketonates with a pyrazole 
ring fused to the chelating moiety, which can be straightforwardly 
obtained by treatment the acylpyrazolone compound, HQR, with a 
base.1 In general, their 2(O,O’)-chelating ability towards transition 
metals is superior with respect to traditional -diketones. The 
presence of the pyrazole ring stabilizes the metal derivatives by 
creating a  conjugate system, when the heterocyclic ring is directly 
bonded to an aromatic substituent. This fact allows the formation of 
stable complexes that are compatible with high oxidation states and 
harsh reaction conditions.1 For instance, some metal-
acylpyrazolonates were shown to possess high catalytic activities in 
oxidation reactions with hydrogen peroxide (epoxidation and alcohol 
oxidation) when the metal was vanadium,2,3 or cerium.4 Concerning 
molybdenum compounds, acylpyrazolonate derivatives were known 
in low oxidation states5 and, in addition, dioxidomolybdenum(VI) 
complexes of general formula [Mo(O)2(QR)2] were synthesised,6,7 
structurally characterised8,9 and their activity as catalysts in 
deoxygenation of epoxides and deoxydehydration of diols were 
recently described by us.10  
 Following our interest in oxido-11 and oxidoperoxido-
molybdenum chemistry,12,13 we here report the synthesis and 
characterization of novel oxidoperoxido-acylpyrazolonate complexes 
of molybdenum, Ph4P[Mo(O)(O2)2(QR)], 1-8, and [Mo(O)(O2)(QR)2], 9-
11, (QR = acylpyrazolonate, see Schemes 1 and 2 below). The 
behaviour of some of these complexes as catalyst precursors in 
epoxidation of selected alkenes, oxidation of selected sulphides and 
deoxygenation of selected epoxide substrates are also here 
described.  
 
Results and discussion 
 
Synthesis and characterization of acylpyrazolonate-
oxidoperoxidomolybdenum(VI) complexes 
The treatment of a solution of [Mo(O)(O)2(H2O)n] with one 
equivalent of acylpyrazolone compounds HQR, in the presence of 
Ph4PCl, produces complexes Ph4P[Mo(O)(O2)2(QR)] (R = neopentyl, 1; 
perfluoroethyl, 2; hexyl, 3; phenyl, 4; naphthyl, 5; methyl, 6; 
cyclohexyl, 7; ethylcyclopentyl, 8). They were isolated in good yields, 
after the appropriate work-up, as yellow crystalline solids (Scheme 
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1). The existence of several strong bands in the IR spectra (1675-1500 
cm-1 range), attributed to ν(CO), ν(CN) and ν(CC), confirmed the 
presence of the acylpyrazolonate ligands in these derivatives.1 The 
(CO) absorption in the free compounds HQR appears at a higher 
frequency (eg. at 1632 cm-1 for HQC6) than in compounds 
Ph4P[Mo(O)(O2)2(QR)] (1630-1600 cm-1 range; at 1618 cm-1 for 3, 
which contains the QC6 ligand), in accordance with the ligand 
coordination to the molybdenum centre. Besides the 
acylpyrazolonate absorptions, the oxido group generates 
characteristic ν(Mo=O) bands at around 950 cm-1 (960-940 cm-1 
range), while the peroxido ligands display distinctive ν(OO), 
νas[Mo(OO)] and νs[Mo(OO)] absorptions close to the expected 
ranges for this ligand: 870-850, 660-650 and 585-572 cm-1, 
respectively.14  
 1H and 13C{1H} NMR spectra of compounds 1-8 show signals 
corresponding to the acylpyrazolonate ligand in agreement with the 
proposed formulation Ph4P[Mo(O)(O2)2(QR)]. These signals are those 
of the common Q skeleton together with the characteristic signals of 
the R substituents in QR ligands. Thus, for example, the 3-methyl 
group (C-1, see notation at Experimental) originated singlets in the 
1H and 13C{1H} NMR spectra centred around 1.3-2.4 ppm and 15-18 
ppm, respectively. The 1-phenyl group gave rise in the 1H NMR to the 
typical pattern doublet:triplet:triplet, 2:2:1, in the 7-8 ppm range and 
in 13C{1H} NMR to four signals in the range 115-140 ppm (ipso, C-6; 
ortho, C-7; meta, C-8; and para, C-9, carbon atoms, see notation at 
Experimental). In addition, the common Q ligand skeleton has three 
carbon atoms of the pyrazole ring along with the carbon atom of the 
acyl group, which gave singlets in the 13C{1H} NMR spectra. Pyrazole 
carbon atoms appeared within the range 135-160 ppm (C-2, C-3 and 
C-4), while the signal of the acyl carbon atom, C-5, arose around 190-
200 ppm (see notation at Experimental). These assignments are 
analogous to other related QR-containing complexes reported in the 
literature.15  
 In a similar way, complexes [Mo(O)(O2)(QR)2] (R = neopentyl, 9; 
hexyl, 10; Cy, 11) were obtained by the reaction of [Mo(O)(O)2(H2O)n] 
with two equivalents of HQR acylpyrazolone compounds, under the 
appropriate reaction conditions (Scheme 2). They were obtained as 
yellow-orange crystalline solids in good yields. Two set of resonances 
were found in the 1H and 13C{1H} NMR spectra for the two 
non-equivalent QR groups in agreement with the proposed 
formulation [Mo(O)(O2)(QR)2], which was further confirmed by X-ray 
crystallography. The NMR spectra of complexes 9-11 additionally 
showed small resonances for extra QR groups that can be assigned to 
isomers of the main product. In fact, four isomers are possible for an 
octahedral oxido-peroxido complex with an asymmetric bidentate 
ligand. Although the X-ray structure of 9 and 10 correspond to only 
one isomer (isomer C, see Scheme 3 below), the computed energies 
for the other three isomers are comparable (see DFT discussion 
below). Consequently, the preferential formation this isomer, shown 
in Scheme 2, is ascribable to kinetic reasons.  
 The molecular structure of the complexes 
Ph4P[Mo(O)(O2)2(QnPe)], 1, Ph4P[Mo(O)(O2)2(QC2F5)], 2, 
[Mo(O)(O2)(QnPe)2], 9, and [Mo(O)(O2)(QC6)2], 10, were determined 
by X-ray methods and the results are shown in Figs. 1-2. Selected 
structural data are included in Table 1. Assuming that peroxido ligand 
occupies one coordination position, complexes 1 and 2 display a 
trigonal bipyramidal structure (bpt) with an axial oxido and two 
equatorial side-on peroxido ligands. The bpt coordination is 
completed by the acylpyrazolonate ligand with the two O-donor 
atoms occupying the remaining axial and equatorial positions. The 
Mo=O oxido distance in 1 and 2 are close to the mean value of 1.68(2) 
Å (range 1.61-1.73 Å) found in mononuclear [Mo(O)(O2)2LeqLax]0/n- 
complexes.14,16,17 Concerning the peroxido ligands, they are side-on 
asymmetrically bonded to molybdenum (see Table 1) and the 
peroxido O-O bond lengths fit well with the mean value of 1.47(2) Å 
for the range 1.35-1.54 Å observed in these complexes.14,16 The Mo1-
O2 bond lengths of ca. 2.3 Å (QR ligand, for 1 and 2) clearly reflect the 
trans influence of the oxido group.  
 
 
Scheme 1 Synthesis of complexes Ph4P[Mo(O)(O2)2(QR)] (1-8) from the corresponding 
acylpyrazolone compounds HQR 
 
Scheme 2 Synthesis of complexes [Mo(O)(O2)(QR)2] (9-11) 
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Fig. 1 Structures of the anions of PPh4[Mo(O)(O2)2(QnPe)], 1, (left) and 
PPh4[Mo(O)(O2)2(QC2F5)], 2, (right). ORTEP diagrams drawing at 30% probability level. 
Hydrogen atoms were omitted for clarity. 
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Table 1 Selected structural parameters of compounds Ph4P[Mo(O)(O2)2(QnPe)], 1, Ph4P[Mo(O)(O2)2(QC2F5)], 2, [Mo(O)(O2)(QnPe)2], 9, and 
[Mo(O)(O2)(QC6)2], 10. 
Bond distances (Å) and angles (°) 1 2 9 10 
Mo=O 1.686(1) 1.680(1) 1.684(2) 1.687(8) 
Mo-O 
(peroxido) 
1.952(1) 
1.918(1) 
1.921(1) 
1.951(1) 
1.904(2) 
1.909(2) 
1.942(2) 
1.947(2) 
1.908(2) 
1.912(2) 
1.885(8) 
1.915(5) 
Mo-O (QR) 
(trans oxido) 2.278(1) 2.325(2) 2.150(2) 2.138(2) 
Mo-O (QR) 
(trans peroxido) - - 2.121(2) 2.138(2) 
Mo-O (QR) 
(cis oxido) 2.081(1) 2.063(1) 
2.027(2) 
2.028(2) 2.0380(19) 
O-O 1.474(2) 1.4707(19) 
1.447(2) 
1.461(2) 1.4162(18) 1.424(6) 
C=O 1.251(2) 1.236(3) 1.266(3) 1.277(3) 1.275(4) 
C-O 1.296(2) 1.288(2) 1.289(3) 1.292(4) 1.299(4) 
O=Mo-O 
(peroxido) 
102.64(7) 
102.21(6) 
101.27(7) 
99.77(7) 
102.84(7) 
102.94(7) 
101.23(8) 
101.31(7) 
102.16(15) 
100.73(13) 
103.2(2) 
102.4(3) 
O=Mo-O (trans) 169.37(6) 171.30(6) 166.08(11) 170.5(3) 
O=Mo-O (cis) 88.99(6) 92.21(6) 
98.20(11) 
89.96(11) 
91.50(11) 
103.4(2) 
90.4(3) 
 
 Complexes 9 and 10 have a distorted octahedral structure where 
two acylpyrazolonate ligands are coordinated to the metal centre 
through two oxygen atoms and the molybdenum six-coordination is 
completed by the presence of mutually cis oxido and peroxido 
groups. In both complexes, the O atoms from the carbonyl moiety of 
the acyl group of each QR ligand (O2 and O4 atoms in 9 or O2 in 10) 
occupy the trans position with respect to the oxido (O5 for 9 and O3 
for 10) and peroxido groups (O6-O7 for 9 and O4-O5 for 10). The 
oxygen atoms of the hydroxido groups of pyrazole in the two QR 
ligands (O1 and O3 for 9 and O1 for 10) are arranged in mutually trans 
positions. The Mo=O bond distances, for both, are similar to those of 
1 and 2 and within the known range for the Mo=O bonds.16 The bond 
distances between the Mo centre and the oxygen atoms of the 
acylpyrazolonate ligands (range 2.02-2.15 Å) are similar as those 
found in other related complexes,10,16 but shorter than the Mo1-O2 
bond lengths of ca. 2.3 Å of 1 and 2. The cis-oxido-peroxido-
molybdenum moiety shows the characteristic O=Mo-O angles higher 
than 90° and the typical distortions from an ideal octahedron of a 
d0-Mo(O)(O2) system.18 Focusing the attention on the ligand Q 
skeleton, in all these complexes the C-O distance (from the hydroxido 
group) is slightly larger than the C−⃛O distance (from the acyl group) 
and this fact suggests a small delocalization on the acylpyrazolonate 
ligand. 
 
DFT study of the possible isomers of Ph4P[Mo(O)(O2)2(QR)] and 
[Mo(O)(O2)(QR)2] complexes 
Acylpyrazolonate ligands are asymmetric in their standard 2(O,O’)-
bidentate coordination to the metal centre and, consequently, two 
possible isomers can be considered for the Ph4P[Mo(O)(O2)2(QR)] 
complexes (A and B in Scheme 3, top). The two possible isomers of 
the anions of complexes 1 and 2 were analysed theoretically by using 
the Density Functional Theory (DFT) approach.19 Geometry 
optimisations were carried out without symmetry restrictions and 
the resulting optimised structures are shown in Fig. 3. All of them are 
stationary points on the potential energy surface (PES) as confirmed 
by the calculations of the frequencies. A comparison between the 
computed structural parameters for the isomer A of the anions of 1 
and 2 and those experimentally found by X-ray diffraction was 
collected in Table S3 (see ESI). In general, a reasonable good 
agreement with experimental data was found. The Mo-O bond 
distances, trans with respect to the oxido group, are slightly 
overestimated (computed distances of ca. 1.705 Å). This is a feature 
Fig. 2 Molecular structures of [Mo(O)(O2)(QnPe)2], 9, (left) and [Mo(O)(O2)(QC6)2], 10, 
(right). ORTEP diagrams drawing at 30% probability level. Hydrogen atoms were omitted 
for clarity. 
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frequently observed in the lengths of ligands that occupy the trans 
position with respect to a ligand with a strong trans influence.20 From 
an energetic point of view, the isomer A is the most stable by ca. 3 
kcal mol-1 (electronic energy) with respect to the isomer B. Although 
this energy difference is small, this result is consistent with the 
experimental structures found for complexes 1 and 2 that 
correspond to the most stable isomer A.  
 Concerning compounds [Mo(O)(O2)(QR)2], the four possible 
isomers C-F (Scheme 3, bottom) of complexes 9 and 10 were also 
theoretically investigated at the same level of theory. All of the 
optimised structures (see Figs. S4 and S5, ESI) were stationary points 
and again the computed structural parameters for the C isomers 
compare well with those experimentally found by X-ray (Table S4). 
From an energetic point of view, the four isomers C-F have roughly 
the same energy with energy differences between them lower than 
1 kcal mol-1 (electronic energy). Taking into account the computed 
energies and considering the C structure found in structurally 
characterised [Mo(O)(O2)(QR)2] complexes, we can suggest a 
mechanism for the preferential formation of isomer C (Scheme 4). 
The first step is the interaction of the parent [Mo(O)(O)2(H2O)n] with 
HQR with water substitution and formation of the anionic 
intermediate [Mo(O)(O2)2(QR)]-. The latter most likely has a type A 
 
Fig. 3 Optimised structures (type A) of the anions of complexes Ph4P[Mo(O)(O2)2(QnPe)], 
1, (left) and Ph4P[Mo(O)(O2)2(QC2F5)], 2, (right). 
 
Scheme 4 Suggested mechanism of preferential formation of complex [Mo(O)(O2)(QR)2], isomer C, with respect to their isomers D-F 
Scheme 3 Possible isomers of [Mo(O)(O2)2(QR)]- anions (A-B) and [Mo(O)(O2)(QR)2] 
complexes (C-F) 
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structure (thermodynamic isomer), being the isomerisation to the 
intermediate with B structure a slow process. The interaction of 
[Mo(O)(O2)2(QR)]-, A, with a second molecule of HQR would produce 
the isomer of type C [Mo(O)(O2)(QR)2] as the kinetic isomer. Small 
amounts of isomer D would appear through a slow isomerisation 
from C, while isomers E and F would be produced by reaction of the 
less stable isomer B of the intermediate [Mo(O)(O2)2(QR)]- with HQR 
and subsequent isomerization, respectively. The isomerization from 
C to D was experimentally proved by heating a sample of complex 10 
(isomer C) at 50 °C for 24 h (see Fig. S6, ESI).  
 
Epoxidation and sulphoxidation reactions using 
Ph4P[Mo(O)(O2)2(QR)] and [Mo(O)(O2)(QR)2] as catalyst precursors 
Two oxidation reactions were selected to evaluate the catalytic 
behaviour of oxidoperoxido-acylpyrazolonate complexes, namely 
epoxidation of cyclohexene and cyclooctene and sulphoxidation of 
methylphenylsulphide and diphenylsulphide (Scheme 5). In all cases, 
30 % aqueous hydrogen peroxide was used as the terminal oxidant, 
with the rest of the reaction conditions being those previously 
optimised for us for these reactions with related oxidoperoxido-Mo-
systems.12,21 For epoxidation, a 1.5:1 oxidant:olefin ratio was 
employed, carrying out the reaction at 60 °C for 18 h in Cl3CH or 
MeOH. For sulphoxidation, the oxidant:sulphide ratio was 1:1 and 
the reaction was performed at 0 or 25 °C for 1 h. Complexes 
Ph4P[Mo(O)(O2)2(QnPe)2], 1, and [Mo(O)(O2)(QnPe)2], 9, were selected 
as representative catalyst precursors. The results obtained are 
shown in Table 2, where other specific experimental details of the 
reaction conditions are included as footnote. Firstly, the activity in 
epoxidation was evaluated (entries 1-4 in Table 2). Complex 1 
showed null activity in the oxidation of cis-cyclooctene (entry 1) and 
medium-low in the case of cyclohexene (entry 3). In the latter case, 
the epoxide selectivity is quite low (18 %) when the reaction was 
carried out in MeOH with formation of both cyclohexane-1,2-diol and 
β-methoxycyclohexanol (33 and 49 %, respectively). In both cases, 
the conversions are lower than those described by our group for 
other oxidoperoxidomolybdenum complexes,12,21 lower than those 
reported for related rhenium complexes22 and lower than those 
observed for complex 9 (entries 2 and 4). In this case, the 
cis-cyclooctene oxidation provides comparable values to those 
previously obtained with other similar Mo-catalysts, even with better 
epoxide selectivity (entry 2).12,21 For the epoxidation of cyclohexene 
(entry 4) the conversion is comparable to the previous substrate (60 
%) with good selectivity to β-methoxycyclohexanol (84 %) obtained 
by epoxide methanolysis. Secondly, the activity of 
Ph4P[Mo(O)(O2)2(QnPe)], 1, and [Mo(O)(O2)(QnPe)2], 9, was 
investigated in the oxidation of selected sulphides (entries 5-9, Table  
Table 2 Oxidation of several substrates with aqueous hydrogen peroxide catalysed by compounds Ph4P[Mo(O)(O2)2(QnPe)], 1, and 
[Mo(O)(O2)(QnPe)2], 9.a 
Entry Catalyst precursor Substrate Conversion (%) Selectivity to epoxide or sulphoxide (%) 
Selectivity to diol or 
sulphone (%) 
1 1 cC8 0 0 0 
2 9 cC8 53 100 0 
3 1 cC6 44 18 33 (49)b 
4 9 cC6 60 0 16 (84)b 
5c 1 PhMeS 31 100 0 
6d 1 PhMeS 94 85 15 
7e 9 PhMeS 95 95 5 
8e,f 9 PhMeS 94 96 4 
9d 1 Ph2S 71 71 29 
a [Mo] = 0.025 mmol, substrate: 1.0 mmol. Epoxidation: [substrate]/[oxidant] ratio: 1:1.5, T = 60 °C, t = 18 h, solvent = 1 ml Cl3CH for cC8, 2 ml MeOH for cC6. 
Sulphoxidation: [substrate]/[oxidant] ratio: 1:1, solvent = 1 ml Cl3CH. See experimental for other details. b In parenthesis: selectivity to β-methoxycyclohexanol. c T = 0 
°C, t = 1 h. d T = 60 °C, t = 18 h. e T = 25 °C, t = 1 h. f Solvent: 1 ml of [C4mim]PF6. cC8 = cis-cyclooctene, cC6 = cyclohexene.  
Scheme 5 Studied epoxidation and sulphoxidation reactions 
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2). Again, the use of 1 in the reaction carried out at 0 °C leads to low 
conversions (entry 5), which are lower than those obtained for us 
with other related oxidodiperoxido-molybdenum catalysts.13 An 
increase in the conversion was only observed when the temperature 
was increased to 60 °C (94 %), with a concomitant decrease in the 
sulphoxide selectivity (85 %, entry 6). Complex 9 is much more active 
in sulphoxidation than the anionic derivative, with high conversions 
and selectivities at 25 °C (ca. 95 %) in both Cl3CH and the ionic liquid 
[C4mim]PF6 (entries 7 and 8, respectively; C4mim = 1-n-butyl-3-
methylimidazolium). These results are similar to those obtained by 
us with the catalyst [Mo(O)(O2)2(H2O)n].13 Conversely to that 
observed by us in other oxidodiperoxido-Mo-ionic liquid systems,12,21 
attempts to recycle the ionic liquid + catalyst mixture were not 
successful in this case since complete leaching of the molybdenum 
catalyst was observed.  
 
Deoxygenation of epoxides using [Mo(O)(O2)(QR)2] complexes as 
catalysts and X-ray structure of [Mo(O)2(QC6)2] 
Oxido-molybdenum complexes are known for their abilities to 
catalyse oxygen atom transfer (OAT) reactions23,24 and other related 
organic transformations.25,26 However, studies of the reaction of 
deoxygenation of epoxides to olefins are not common.27,28 For this 
reason, the catalytic activity of [Mo(O)(O2)(QR)2] complexes in the 
deoxygenation of epoxides, using PPh3 as oxygen acceptor, was also 
investigated (Scheme 6). Complexes [Mo(O)(O2)(QC6)2], 10, and 
[Mo(O)(O2)(QCy)2], 11, were selected as representative catalyst  
precursors and Ph4P[Mo(O)(O2)2(QR)2] derivatives were not tested 
due to their low catalytic activity. The selected reaction conditions 
were similar to those previously optimised for [Mo(O)2(QR)2]  
complexes,10 namely 18 h of reaction at 120 °C in toluene as solvent. 
As shown Table 3, the best results are obtained for the 
deoxygenation of stilbene and styrene oxides with complete 
conversion and a selectivity to the corresponding olefin for both 10 
and 11 catalyst precursors (entries 1-4). In the case of cyclic epoxides 
(entries 5-8) or for the linear epoxide oct-1-ene (entries 9-10), the 
conversion values were somewhat lower, detecting only in the case 
of cyclohexene oxide a selectivity of 100 % to the corresponding 
olefin. Analysis of the 31P{1H} NMR reaction showed in all cases the 
complete consumption of the phosphane PPh3 to O=PPh3.  
 In order to investigate the epoxide deoxygenation mechanism, 
the stoichiometric reaction of complex [Mo(O)(O2)(QC6)2], 10, with 
one equivalent of PPh3 was carried out on a preparative scale. From 
the resulting orange reaction solution, it was possible to isolate 
yellow crystals of complex 12, which were spectroscopically and 
structurally characterised. The IR spectrum and 1H and 13C{1H} NMR 
spectra were analogous to those of dioxidomolybdenum complex 
[Mo(O)2(QC6)2], previously described by us.10  
 
Table 3 Deoxygenation of epoxides with PPh3 using [Mo(O)(O2)(QR)2] catalyst precursors.a 
Entry Catalyst precursor Substrate Conversion (%) Selectivity to alkene (%) 
1 10 trans-stilbene oxide 100 100 
2 11 trans-stilbene oxide  100 100 
3 10 styrene oxide 100 100 
4 11 styrene oxide 100 100 
5 10 cyclooctene oxide 83 58 
6 11 cyclooctene oxide 80 56 
7 10 cyclohexene oxide 49 100 
8 11 cyclohexene oxide 57 100 
9 10 oct-1-ene oxide 85 60 
10 11 oct-1-ene oxide 79 57 
a [Mo] = 0.025 mmol, substrate = 0.5 mmol, [substrate]/[PPh3] ratio: 1:1, solvent 2.0 ml toluene, T = 120 °C, t = 18 h. See experimental for other details.  
 
Scheme 6 Epoxide deoxygenation with PPh3 catalyzed by [Mo(O)(O2)(QR)2] complexes 
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This result demonstrates that the first step in the epoxide 
deoxygenation reaction, using [Mo(O)(O2)(QR)2] complexes, is the 
OAT reaction of one of the oxygen atoms of complex 10 to the PPh3 
substrate. This would produce the [Mo(O)2(QR)2] species that 
behaves as intermediate and that could be involved in a second OAT 
reaction in which the oxido group will undergo the second transfer 
to the PPh3 phosphane. The formation of complex [Mo(O)2(QC6)2], 12, 
was confirmed by X-ray diffraction. Curiously, the structure of this 
complex (Fig. 4) is a polymorph of that previously described.10 
Probably, the use of different crystallization solvents may explain the 
formation of these polymorphs that show structural differences in 
the hexyl group conformations (see Fig. S1). Other structural 
parameters are quite similar and does not require further comments 
(see Table S2).  
Conclusions 
Complexes Ph4P[Mo(O)(O2)2(QR)] (R = neopentyl, 1; 
perfluoroethyl, 2; hexyl, 3; phenyl, 4; naphthyl, 5; methyl, 6; 
cyclohexyl, 7; ethylcyclopentyl, 8) and [Mo(O)(O2)(QR)2] (R = 
neopentyl, 9; hexyl, 10; cyclohexyl, 11) were synthesised and 
characterised spectroscopically, theoretically and structurally 
(1, 2, 9 and 10). The epoxidation of selected alkenes and 
oxidation of selected sulphides with aqueous hydrogen 
peroxide was investigated using these 
acylpyrazolonate-oxidoperoxido molybdenum(VI) complexes as 
catalyst precursors. Low activity were noticed for anionic 
compounds, while better results in epoxidation and 
sulphoxidation were observed for neutral complexes (for 
example, conversion and selectivity of 95 % in sulphoxidation of 
methylphenylsulphide using 9 as catalyst precursor). The 
selective and efficient deoxygenation of styrene oxide and 
trans-stilbene oxide substrates, employing PPh3 and using 
complexes [Mo(O)(O2)(QR)2] as catalysts, was demonstrated. 
The first step in the epoxide deoxygenation mechanism was the 
oxygen atom transfer to the phosphane. This was demonstrated 
through the stoichiometric reaction of 10 with one equivalent 
of PPh3, carried out on a preparative scale, which afforded 
complex [Mo(O)2(QCy)2], 12.  
 
Experimental 
 
General. All preparations and other operations were carried out 
under dry aerobic conditions. Solvents were dried using standard 
procedures. Ph4PCl and MoO3 were purchased from Aldrich and they 
were used as supplied. Acylpyrazolones HQR compounds1,29 and 
[Mo(O)(O)2(H2O)n]30 were prepared as previously reported. Infrared 
spectra were recorded on Perkin-Elmer FT-IR Spectrum Two 
spectrophotometer (KBr pellet or Nujol emulsion in NaCl plates or 
using the ATR technique). NMR spectra were run on Bruker AMX-300 
or Avance III spectrometers at the Centro de Investigaciones, 
Tecnología e Innovación (CITIUS) of the University of Sevilla. 1H and 
13C{1H} NMR shifts were referenced to the residual signals of 
deuterated solvents, while 31P{1H} shifts were referenced to external 
85 % phosphoric acid. The gas chromatograms (GC) were obtained 
using a Varian Chromatogram CP-3800 with nitrogen as the carrier 
gas. The chromatogram used a Varian automatic injector, model CP-
8410, flame ionisation detector (FID), and a Varian column, model 
CP-8741. Microanalyses (C, H, N) were carried out by CITIUS at the 
Universidad of Sevilla.  
 
Syntheses  
Ph4P[Mo(O)(O2)2(QR)] complexes (1-8): Complex 1 was prepared as 
follows: over a solution of compound HQnPe (67 mg, 0.25 mmol) in 
ethanol (5 ml) was added dropwise a solution of Ph4PCl (93 mg, 0.25 
mmol) in ethanol (5 ml). The mixture was stirred for 30 min at room 
temperature. Then, over the resulting solution was added dropwise 
1 ml of an aqueous 0.25 M solution of complex [Mo(O)(O2)2(H2O)n]. 
The mixture was further stirred for 1 h at room temperature. The 
resulting solution was cooled to 4 °C. After 48 h yellow-orange 
crystals of complex 1 were obtained. Yield: 68 % (132 mg). Complexes 
2-8 were prepared following the same experimental procedure but 
using the appropriate HQR compound. For the notation of 1H and 13C 
signals, see the following scheme:  
Fig. 4 Molecular structure of [Mo(O)2(QC6)2], 12. ORTEP diagram drawing at 30% 
probability level. Hydrogen atoms were omitted for clarity. 
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Ph4P[Mo(O)(O2)2(QnPe)], 1: IR (cm-1, KBr): 3419 (br), 3055 (m), 2951 
(m), 1611 (vs), 1596 (s), 1524 (vs), 1487 (s), 1441 (vs), 1401 (m), 1364 
(m), 1316 (m), 1272 (w), 1231 (w), 1189 (w), 1167 (w), 1157 (w), 1109 
(vs), 1079 (s), 1029 (w), 997 (m), 951 (vs), 973 (m), 863 (vs), 811(w), 
762 (s), 724(vs), 691 (vs), 655 (s), 609(w), 581 (m), 528 (vs), 456 (brw). 
1H NMR (CDCl3, 300 Hz):  = 0.94 (s, 9H, CH-a), 2.36 (s, 2H, CH-c), 2.41 
(s, 3H, CH-1), 7.08 (t, 1H, J = 7 Hz, CH-9), 7.25 (t, 2H, J = 7 Hz, CH-8), 
7.58 (m, 8H, CH meta PPh), 7.73 (m, 8H, CH ortho PPh), 7.83 (m, 4H, 
CH para PPh), 8.0 (d, 2H, J = 7 Hz, CH-7). 13C{1H} NMR (CDCl3, 75.47 
Hz):  = 17.6 (s, C-1), 30.1 (s, C-a), 32.5 (s, C-b), 49.7 (s, C-c), 106.5 (s, 
C-3), 116.9 (s, C-7), 118.1 (s, C-8), 121.0 (s, C-9), 125.1 (s, C-4), 128.5 
(s, C para PPh), 130.7 (s, C ortho PPh), 134.4 (s, C meta PPh), 135.7 (s, 
C ipso PPh), 138.8 (s, C-6), 147.8 (s, C-2), 194.4 (s, C-5). 31P{1H} NMR 
(CDCl3):  = 23.0 (s, PPh4). C40H39MoN2O7P: calcd. C 61.07, H 5.00, N 
3.56; found C 61.73, H 5.27, N 3.65 %.  
Ph4P[Mo(O)(O2)2(QC2F5)], 2: Yield: 37 % (8 mg). IR (cm-1, KBr): 3444 
(br), 3062 (w), 1631 (vs), 1596 (m), 1528 (m), 1488 (m), 1438 (s), 1384 
(w), 1344 (w), 1319 (m), 1226 (m), 1205 (m), 1183 (vs), 1109 (s), 1065 
(m), 1042 (w), 1019 (w), 997 (w), 960 (s), 904 (w), 867 (s), 760 (w), 
750 (w), 724 (s), 689 (m), 658 (m), 629 (w), 586 (m), 527 (s). 1H NMR 
(CDCl3, 300 Hz):  = 2.36 (s, 3H, CH-1), 7.20 (t, J = 7.5, 1H, CH-9), 7.36 
(t, J = 7.5, 2H, CH-8), 7.59-7.66 (m, 8H, CH meta PPh), 7.76 (td, 8H, CH 
ortho PPh), 7.84-7.89 (m, 4H, CH para PPh), 8.00 (d, J = 7.5, 2H, CH-
7). 13C{1H} NMR (CDCl3, 75.47 Hz):  = 16.6 (s, C-1), 116.9 (s, C-7), 
118.1 (s, C-8), 121.4 (s, C-9), 125.9 (s, C-4), 128.7 (s, C para PPh), 130.7 
(s, C ortho PPh), 134.4 (s, 8CH, C meta PPh), 135.7 (s, C ipso PPh), 
137.9 (s, C-6), 147.7 (s, C-2), 164.8 (s, C-3), 214.9 (s, C-5), CF2CF3 not 
observed. 31P{1H} NMR (CDCl3):  = 23.1 (s, PPh4). C37H28F5MoN2O7P: 
calcd. C 53.25, H 3.38, N 3.36; found C 53.96, H 3.32, N 3.26 %.  
Ph4P[Mo(O)(O2)2(QC6)], 3: Yield: 61 % (123 mg). ATR-IR (cm-1): 3060 
(w), 2960 (w), 2922 (w), 1618 (s), 1597 (m), 1585 (m), 1520 (m), 1495 
(m), 1484 (w), 1463 (w), 1455 (w), 1437 (s), 1403 (w), 1387 (w), 1315 
(w), 1227 (w), 1187 (w), 1161 (w), 1107 (s), 1076 (m), 1026 (w), 996 
(m), 951 (s), 910 (w), 872 (w), 855 (s), 760 (m), 752 (m), 722 (s), 691 
(s), 657 (m), 647 (m), 629 (w), 614 (w), 579 (m), 525 (vs), 492 (w), 458 
(w), 445 (w). 1H NMR (CDCl3, 300 Hz):  = 0.82 (t, J = 7, 3H, CH-a), 1.21 
(m, 6H, CH-b, CH-c, CH-d), 1.46 (m, 2H, CH-e), 2.37 (s, 3H, CH-1), 2.43 
(t, J = 7.5, 2H, CH-f), 7.09 (t, J = 7.5, 1H, CH-9), 7.27 (m, 2H, CH-8), 
7.56-7.62 (m, 8H, CH meta PPh), 7.70-7.75 (m, 8H, CH ortho PPh), 
7.79-7.84 (m, 4H, CH para PPh), 8.00 (d, J = 7.5, 2H, CH-7). 13C{1H} 
NMR (CDCl3, 75.47 Hz):  = 14.0 (s, C-a), 16.8 (s, C-1), 22.5 (s, C-b), 
25.2 (s, C-c), 29.1 (s, C-d), 31.5 (s, C-e), 39.6 (s, C-f), 104.7 (s, C-3), 
116.9 (s, C-7), 118.1 (s, C-8), 121.1 (s, C-9), 125.0 (s, C-4), 128.5 (s, C 
para PPh), 130.7 (s, C ortho PPh), 134.4 (s, C meta PPh), 135.6 (s, C 
ipso PPh), 138.8 (s, C-6), 147.8 (s, C-2), 194.9 (s, C-5). 31P{1H} NMR 
(CDCl3):  = 22.9 (s, PPh4). C42H43MoN2O7P: calcd. C, 61.27; H, 5.52; 
N, 3.49; found: C, 61.33; H, 5.22; N, 3.44 %.  
Ph4P[Mo(O)(O2)2(QPh)], 4: Yield: 76 % (152 mg). ATR-IR (cm-1): 3056 
(w), 1605 (m), 1523 (w), 1482 (m), 1435 (m), 1369 (w), 1107 (m), 
1082 (w), 953 (m), 862 (m), 783 (w), 757 (w), 722 (s), 688 (s), 653 (m), 
618 (w), 581 (m), 525 (vs), 438 (w). 1H NMR (CDCl3, 300 Hz):  = 1.80 
(s, 3H, CH-1), 7.16 (t, J = 7.5, 1H, CH-9), 7.26 (t, J = 7.5, 2H, CH-8), 
7.32-7.38 (m, 5H, CH-a, CH-b, CH-c), 7.56-7.64 (m, 8H, CH meta PPh), 
7.69-7.76 (m, 8H, CH ortho PPh), 7.79-7.84 (m, 4H, CH para PPh), 8.06 
(d, J = 7.5, 2H, CH-7). 13C{1H} NMR (CDCl3, 75.47 Hz):  = 16.2 (s, C-1), 
105.1 (s, C-3), 116.9 (s, C-7), 118.1 (s, C-4), 121.2 (s, C-8), 125.3 (s, C-
a), 127.5 (s, C-b), 128.2 (s, C-c), 128.6 (s, C-9), 130.3 (s, C para PPh), 
130.6 (s, C ortho PPh), 134.3 (s, C meta PPh), 135.6 (s, C ipso PPh), 
138.7 (s, C-d), 139.4 (s, C-6), 148.7 (s, C-2), 190.2 (s, C-5) 31P{1H} NMR 
(CDCl3):  = 23.0 (s, PPh4). C41H33MoN2O7P: calcd. C, 61.89; H, 4.56; 
N, 3.52; found: C, 60.67; H, 4.43; N, 3.51 %.  
Ph4P[Mo(O)(O2)2(QNaph)], 5: Yield: 55 % (116 mg). ATR-IR (cm-1): 3056 
(w), 1600 (w), 1574 (w), 1525 (w), 1482 (w), 1433 (m), 1163 (s), 1106 
(m), 1022 (w), 997 (w), 948 (m), 862 (m), 842 (w), 754 (m), 723 (s), 
707 (m), 687 (s), 652 (m), 626 (w), 614 (w), 580 (m), 524 (vs), 451 (w), 
408 (w). 1H NMR (CDCl3, 300 Hz):  = 1.33 (s, 3H, CH-1), 7.11 (t, J = 
7.5, 1H, CH-9), 7.2-7.3 (m, 6H, CH-8, CH-g, CH-f), 7.50-7.57 (m, 8H, CH 
meta PPh), 7.64-7.81 (m, 14H, CH-7, CH ortho PPh, CH para PPh), 7.92 
(d, J = 7.5, 1H, CH-b), 8.06 (d, J = 7.8, 2H, CH-c). 13C{1H} NMR (CDCl3, 
75.47 Hz):  = 15.2 (s, C-1), 106.6 (s, C-3), 116.8 (s, C-7), 118.0 (s, C-
8), 121.1 (s, C-9), 124.3 (s, C-c), 125.3 (s, C-b), 126.0 (s, C-4), 126.7 (s, 
C-f), 127.6 (s, C-g), 128.6 (s, C para PPh) 129.2 (s, C-e), 130.4 (s, C-d) 
130.6 (s, C ortho PPh), 133.1 (s, C-a), 134.3 (s, C meta PPh), 135.5 (s, 
C ipso PPh), 138.6 (s, C-6), 149.3 (s, C-2), 190.2 (s, C-5). 31P{1H} NMR 
(CDCl3):  = 23.0 (s, PPh4). C45H35MoN2O7P: calcd. C, 63.91; H, 4.53; 
N, 3.31; found: C, 63.32; H, 4.21; N, 3.47 %.  
Ph4P[Mo(O)(O2)2(QMe,CF3)], 6: Yield: 56 % (113 mg). ATR-IR (cm-1): 
3063 (w), 1622 (m), 1611 (m), 1586 (w), 1530 (m), 1496 (m), 1480 
(m), 1435 (m), 1423 (m), 1384 (w), 1321 (s), 1156 (m), 1106 (s), 1087 
(m), 1068 (s), 1012 (w), 997 (w), 972 (w), 952 (m), 869 (w), 858 (m), 
779 (w), 755 (m), 722 (s), 690 (m), 679 (w), 650 (s), 615 (w), 578 (m), 
524 (vs), 453 (w), 439 (m), 404 (w). 1H NMR (CDCl3, 300 Hz):  = 2.17 
(s, 3H, CH3-CO), 2.36 (s, 3H, CH-1), 7.53 (d, J = 7.5, 2H, CH-8), 7.56-
7.63 (m, 8H, CH meta PPh), 7.71-7.76 (m, 8H, CH ortho PPh), 7.82-
7.87 (m, 4H, CH para PPh), 8.21 (d, J = 7.5, 2H, CH-7). 13C{1H} NMR 
(CDCl3, 75.47 Hz):  = 16.8 (s, C-1), 27.7 (s, CH3-CO), 105.3 (s, C-3), 
116,8 (s, C-7), 118.0 (s, C-8), 120.4 (s, C-9), 122.4 (s, CF3) 125.7 (s, C-
4), 130.7 (s, C ortho PPh), 134.3 (s, C meta PPh), 135.7 (s, C para PPh), 
141.5 (s, C ipso PPh), 149.1 (s, C-2), 162.3 (s, C-6), 192.1 (s, C-5) 
31P{1H} NMR (CDCl3):  = 23.0 (s, PPh4). C37H30F3MoN2O7P: calcd. C, 
55.65; H, 3.79; N, 3.51; found: C, 55.94; H, 3.76; N, 3.58 %.  
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Ph4P[Mo(O)(O2)2(QCy)], 7: Yield: 68 % (136 mg). ATR-IR (cm-1): 3470 
(w), 2920 (w), 2845 (w), 1609 (m), 1584 (w), 1517 (m), 1485 (m), 1454 
(w), 1433 (m), 1392 (w), 1313 (w), 1160 (w), 1106 (m), 1078 (m), 1029 
(w), 997 (w), 979 (w), 944 (m), 893 (w), 869 (m), 853 (m), 814 (w), 
789 (w), 753 (m), 718 (s), 687 (s), 653 (m), 625 (w), 616 (w), 580 (m), 
524 (vs), 464 (m), 447 (w). 1H NMR (CDCl3, 300 Hz):  = 1.06-1.75 
(several m, 11H, C6H11-CO), 2.39 (s, 3H, CH-1), 7.09 (t, J = 7.5, 1H, CH-
9), 7.27 (t, J = 7.5, 2H, CH-8), 7.55-7.62 (m, 8H, CH meta PPh), 7.69-
7.76 (m, 8H, CH ortho PPh), 7.79-7.84 (m, 4H, CH para PPh), 7.99 (d, 
J = 7.5, 2H, CH-7). 13C{1H} NMR (CDCl3, 75.47 Hz):  = 16.6 (s, C-1), 
18.4 (s, C-b), 25.7 (s, C-c), 28.7 (s, C-d), 46.0 (s, C-a), 104.0 (s, C-3), 
116.9 (s, C-7), 118.0 (s, C-8), 121.1 (s, C-9), 125.0 (s, C-4), 128.5 (s, C 
para PPh), 130.7 (s, C ortho PPh), 134.3 (s, C meta PPh), 135.6 (s, C 
ipso PPh), 138.8 (s, C-6), 147.4 (s, C-2), 197.8 (s, C-5). 31P{1H} NMR 
(CDCl3):  = 23.0 (s, PPh4). C41H39MoN2O7P: calcd. C, 61.66; H, 4.92; 
N, 3.51; found: C, 61.51; H, 5.21; N, 3.36 %.  
Ph4P[Mo(O)(O2)2(QEtCp)], 8: Yield: 39 % (80 mg). ATR-IR (cm-1): 3062 
(w), 1618 (w), 1584 (w), 1522 (w), 1482 (w), 1435 (m), 1393 (w), 1339 
(w), 1314 (w), 1186 (w), 1164 (w), 1106 (s), 1073 (w), 1025 (w), 995 
(m), 976 (s), 871 (s), 751 (m), 721 (s), 688 (s), 652 (m), 603 (m), 559 
(m), 523 (vs), 448 (w). 1H NMR (CDCl3, 300 Hz):  = 0.94-1.10 (m, 2H, 
CH-d), 1.39-1.57 (m, 5H, CH-a, CH-c), 1.60-1.74 (m, 4H, CH-b), 2.38 (s, 
3H, CH-1), 2.45 (t, J = 7.5, 2H, CH-e), 7.10 (t, J = 7.5, 1H, CH-9), 7.27 
(t, J = 7.5, 2H, CH-8), 7.55-7.62 (m, 8H, CH meta PPh), 7.69-7.76 (m, 
8H, CH ortho PPh), 7.79-7.84 (m, 4H, CH para PPh), 8.00 (d, J = 7.5, 
2H, CH-7). 13C{1H} NMR (CDCl3, 75.47 Hz):  = 16.8 (s, C-1), 25.0 (s, C-
a), 31.1 (s, C-c), 32.4 (s, C-b), 38.9 (s, C-d), 40.2 (s, C-e), 104.7 (s, C-3), 
116.9 (s, C-7), 118.0 (s, C-8), 121.1 (s, C-9), 125.0 (s, C-4), 128.5 (s, C 
para PPh), 130.6 (s, C ortho PPh), 134.3 (s, C meta PPh), 135.6 (s, C 
ipso PPh), 138.8 (s, C-6), 147.8 (s, C-2), 195.0 (s, C-5). 31P{1H} NMR 
(CDCl3):  = 23.0 (s, PPh4). C42H41MoN2O7P: calcd. C, 62.07; H, 5.08; 
N, 3.45; found: C, 62.19; H, 5.14; N, 3.39 %.  
 
[Mo(O)(O2)(QR)2] complexes (9-11): Over a solution of compound 
HQR (1 mmol) in methanol (10 ml) was added dropwise 0.5 mmol of 
an aqueous 0.25 M solution of complex [Mo(O)(O2)2(H2O)n]. After 2h 
of stirring at room temperature, a yellow-orange solid was formed. 
It was isolated by filtration, washed with acetone and dried. From the 
solution a further crop was obtained. The solid fractions were 
recrystallised from diethyl ether or methanol.  
[Mo(O)(O2)(QnPe)2], 9: Yield: 72 % (251 mg). IR (cm-1, KBr): 3419 (br), 
2957 (m), 1604 (s), 1560 (vs), 1536 (vs), 1486 (s), 1442 (s), 1412 (s), 
1376 (s), 1354 (m), 1275 (m), 1226 (m), 1078 (s), 1066 (s), 1009 (m), 
952 (s), 951 (s), 912 (m), 814 (m), 754 (s), 689 (m), 656 (m), 636 (m), 
612 (w), 562(m), 505 (w), 472 (m). 1H NMR (CDCl3, 300 Hz):  = 0.87 
(s, 9H, CH-a), 1.04 (s, 9H, CH-a), 2.33 (AB system, Jap = 14, 2H, CH-c), 
2.50 (s, 3H, CH-1), 2.54, (s, 3H, CH-1), 2.91 (AB system, Jap = 14, 2H, 
CH-c), 7.37 (m, 2H, CH-9), 7.53 (m, 4H, CH-8), 8.11 (m, 4H, CH-7). 
13C{1H} NMR (CDCl3, 75.47 Hz):  = 16.9 (s, C-1), 17.3 (s, C-1), 29.8 (s, 
C-a), 30.0 (s, C-a), 32.7 (s, C-b), 33.3 (s, C-b), 49.0 (s, C-c), 108.9 (s, C-
3), 109.9 (s, C-3), 121.5 (s, C-7), 121.6 (s, C-7), 126.7 (s, C-9), 127.1 (s, 
C-9), 128.9 (s, C-4), 128.7 (s, C-4), 129.0 (s, C-8), 129.2 (s, C-8), 137.2 
(s, C-6), 137.6 (s, C-6), 148.8 (s, C-2), 148.9 (s, C-2), 194.5 (s, C-5), 
195.8 (s, C-5). C32H38MoN4O7: calcd. C 55.98, H 5.58, N 8.16; found C 
56.88, H 5.60, N 8.03 %.  
[Mo(O)(O2)(QC6)2], 10: Yield: 68 % (433 mg). IR (cm-1, KBr): 3462 (br), 
2928 (s), 1608 (vs), 1561 (vs), 1532 (vs), 1490 (vs), 1444 (vs), 1419 (s), 
1384 (s), 1354 (m), 1129 (m), 1077 (s), 1061 (s), 1037 (m), 1011 (m), 
987 (m), 954 (s), 930 (s), 847 (m), 764 (s), 742 (m), 690 (m), 657 (m), 
612 (w), 627(m), 560 (m), 462 (m). 1H NMR (CDCl3, 300 Hz):  = 0.82 
(m, 6H, 2 x CH-a), 1.25 (m, 12H, 2 x (CH-b, CH-c, CH-d)), 1.60 (m, 4H, 
2 x CH-e), 2.47 (s, 3H, CH-1), 2.55 (s, 3H, CH-1), 2.88 (t, J = 7, 4H, 2 x 
CH-f), 7.37 (m, 2H, 2 x CH-9), 7.54 (m, 4H, 2 x CH-8), 8.11 (dd, J = 7.5, 
4H, 2 x CH-7). 13C{1H} NMR (CDCl3, 75.47 Hz):  = 13.9 (s, C-1), 15.3 (s, 
C-1), 16.3 (s, C-a), 16.6 (s, C-a), 22.4 (s, C-b), 22.6 (s, C-b), 25.2 (s, C-
c), 25.5 (s, C-c), 28.8 (s, C-d), 28.9 (s, C-d), 31.5 (s, C-e), 31.6 (s, C-e), 
37.5 (s, C-f), 37.7 (s, C-f), 107.2 (s, C-3), 108.3 (s, C-3), 121.6 (s, C-7), 
121.7 (s, C-7), 126.7 (s, C-9), 127.1 (s, C-9), 129.1 (s, C-8), 129.2 (s, C-
8), 137.3 (s, C-4), 137.6 (s, C-4),), 148.7 (s, C-6), 148.8 (s, C-6), 161.1 
(s, C-2), 161.5 (s, C-2), 194.9 (s, C-5), 196.4 (s, C-5). C34H42MoN4O7: 
calcd. C 57.14, H 5.92, N 7.84; found C 57.42, H 5.95, N 7.68 %.  
[Mo(O)(O2)(QCy)2], 11: Yield: 38 % (132 mg). IR (cm-1, KBr): 3457 (br), 
2932 (s), 2855 (s), 1608 (vs), 1560 (vs), 1533 (vs), 1490 (vs), 1443 (vs), 
1418 (s), 1377 (s), 1360 (m), 1081 (s), 1070 (m), 1035 (m), 1009 (m), 
984 (m), 952 (s), 930 (s), 850 (m), 818 (m), 757 (s), 689 (m), 658 (m), 
629 (m), 558 (m), 461 (m). 1H NMR (CDCl3, 300 Hz):  = 1.02-2.12 
(several m, 20H, 2 x (CH-b, CH-c, CH-d)), 2.30 and 2.57 (s, 6H, 2 x CH-
1), 2.65-3.40 (m, 2H, 2 x CH-a), 7.10-7.70 (m, 6H, 2 x (CH-9, CH-8)), 
7.80-8.20 (m, 2H, 2 x CH-7). 13C{1H} NMR (CDCl3, 75.47 Hz):  = 16.2 
(s, C-1), 16.3 (s, C-1), 25.4, 25.6, 25.7, 25.8 (s, 2 x (C-d, C-c)), 28.8, 29.6 
(s, 2 x C-b), 45.1, 45.6 (s, 2 x C-a), 106.2 (s, C-3), 107.1 (s, C-3), 120.1, 
121.8 (s, 2 x C-7), 126.7, 127.1 (s, 2 x C-9), 129.0, 129.2 (s, 2 x C-8), 
136.9, 137.3 (s, 2 x C-6), 148.2 (s, C-2), 149.0 (s, C-2), 161.3 (s, C-4), 
161.9 (s, C-4), 197.5 (s, C-5), 199.5 (s, C-5). C34H38MoN4O7: calcd. C 
57.47, H 5.39, N 7.88; found C 57.69, H 5.21, N 7.45 %.  
[Mo(O)2(QHe)2], 12: Over a solution of [Mo(O)(O2)(QC6)2], 10, (72 mg, 
0.1 mmol) in Et2O (15 ml), PPh3 (26 mg, 0.1 mmol) was added. The 
mixture was stirred for 2h, during this time, the resulting yellow 
solution darkens to orange, and then the solution was cooled to -20 
°C. After 24 hours yellow crystals were obtained, which were 
collected by filtration and dried under vacuum. Yield: 54 % (37 mg). 
The spectroscopic data of 12 (IR and 1H and 13C{1H} NMR) were 
similar to those previously described by us.10  
 
Catalytic assays 
General procedure for olefin epoxidations. The reactor (a 50 ml vial 
equipped with a Young valve and a magnetic stirrer flea) was charged 
with the corresponding solid catalyst (0.025 mmol, 1 or 9), methanol 
(2 ml) or CHCl3 (1 ml), 30 % aqueous hydrogen peroxide (170 μl, 1.5 
mmol) and the corresponding olefin (1 mmol), in the aforementioned 
order. The reactor was sealed and heated at 60 °C, maintaining 
constant stirring (600 rpm) in a thermostatted oil bath for the 
duration of the reaction (18 h). Upon completion, the reactor was 
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immediately cooled to 0 °C (ice bath) and the products were 
extracted with diethyl ether (6x3 ml). The resulting solution was 
dried (anhydrous MgSO4) and analysed by GC, using 50 μl of n-octane 
as internal standard.  
General procedure for sulphoxidation reactions. The reactor (a 50 
ml vial equipped with a Young valve and a magnetic stirrer flea) was 
charged with the corresponding solid catalyst (0.025 mmol, 1 or 9), 
chloroform (2 ml) or [C4mim]PF6 (1 ml), 30 % aqueous hydrogen 
peroxide (1 mmol per each mmol of sulphide) and the corresponding 
sulphide (PhMeS or Ph2S, 1 mmol), in the aforementioned order. The 
reactor was sealed and cooled to 0 °C (or 25 °C), maintaining constant 
stirring (600 rpm) in a thermostatted bath for the duration of the 
reaction. Upon completion, the mixture was treated with diethyl 
ether (10 ml) and filtered with 0.45 m nylon syringe filter. The 
resulting solution was analysed by GC, using 50 μl of dodecane as 
internal standard.  
General procedure for epoxide deoxygenations. The reactor (a 50 
ml vial equipped with a Young valve and a magnetic stirrer flea) was 
charged with the corresponding solid catalyst (0.025 mmol, 10 or 11), 
PPh3 (131 mg, 0.5 mmol), toluene (2 ml) and the corresponding olefin 
oxide (0.5 mmol), in the aforementioned order. The reactor was 
sealed and heated at 120 °C, maintaining constant stirring (600 rpm) 
in a thermostatted oil bath for the duration of the reaction (18 h). 
Upon completion, the mixture was cooled to 0 °C (ice bath) and 
analysed by 31P{1H} NMR. Then, the solution was evaporated to 
dryness, the resulting residue extracted with ethanol (10 ml) and 
filtered with 0.45 m nylon syringe filter to remove the undissolved 
triphenylphosphane oxide. The resulting solution was analysed by 
GC, using 50 μl of dodecane as internal standard.  
Computational details 
The electronic structure and geometries of the isomers of the anions 
of complexes 1 and 2 were computed using density functional theory 
at the B3LYP level.31 The Mo atom was described with the LANL2DZ 
basis set32 while the 6-311+G** basis set was used for the C, O, N and 
H atoms. The optimised geometries of all the compounds were 
characterised as energy minima by a nonexistence of imaginary 
frequencies (NImag = 0) in the diagonalisation of the analytically 
computed Hessian (vibrational frequencies calculations). The DFT 
calculations were performed using the Gaussian 09 suite of 
programmes.33 For coordinates of the optimised compounds, see 
Table S4 (ESI).  
X-ray crystallography 
A summary of the crystallographic data and structure refinement 
results for compounds 1-2, 9-10 and 12 is given in Table S2 (ESI). 
Crystals of suitable size for X-ray diffraction analysis were coated 
with dry perfluoropolyether and mounted on glass fibers and fixed in 
a cold nitrogen stream (T = 213 K) to the goniometer head. Data 
collection was performed on a Bruker-Nonius X8Apex-II CCD 
diffractometer, using monochromatic radiation λ(Mo Kα) = 0.71073 
Å, by means of ω and φ scans with a width of 0.50 degree. The data 
were reduced (SAINT)34 and corrected for absorption effects by the 
multi-scan method (SADABS).35 The structures were solved by direct 
methods (SIR-2002)36 and refined against all F2 data by full-matrix 
least-squares techniques (SHELXL-2016/6)37 minimizing w[Fo2-Fc2]2. 
All non-hydrogen atoms were refined anisotropically. The hydrogen 
atoms were included from calculated positions and refined riding on 
their respective carbon atoms with isotropic displacement 
parameters. The crystal structures of complexes 9 and 10 show the 
oxido and peroxido groups disordered over two sets of atomic sites 
where both groups alternate with each other. While in complex 9 
both disordered groups are located over general positions with 
refined occupancy coefficients in a 7:3 ratio, in 10 both groups are 
located around a C2 axis that passes through the Mo atom and 
generates by symmetry the whole complex (only half complex 
appears in the asymmetric unit). For this reason, both disordered 
groups have identical occupancy. Some geometric restraints (DFIX 
instruction), the ADP restraint SIMU and the rigid bond restraint 
DELU were used to make the geometric and ADP values of the 
disordered atoms more reasonable.  
CCDC 1580360 - 1580364 (for 1, 2, 9, 10 and 12, respectively) 
contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
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